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Ciliopathies are a group of hereditary disorders associated with defects in cilia structure and function. The distal appendages (DAPs) of
centrioles are involved in the docking and anchoring of the mother centriole to the cellular membrane during ciliogenesis. The molec-
ular composition of DAPs was recently elucidated and mutations in two genes encoding DAPs components (CEP164/NPHP15, SCLT1)
have been associated with human ciliopathies, namely nephronophthisis and orofaciodigital syndrome. To identify additional DAP
components defective in ciliopathies, we independently performed targeted exon sequencing of 1,221 genes associated with cilia
and 5 knownDAP protein-encoding genes in 1,255 individuals with a nephronophthisis-related ciliopathy.We thereby detected biallelic
mutations in a key component of DAP-encoding gene, CEP83, in seven families. All affected individuals had early-onset nephrono-
phthisis and four out of eight displayed learning disability and/or hydrocephalus. Fibroblasts and tubular renal cells from affected
individuals showed an altered DAP composition and ciliary defects. In summary, we have identified mutations in CEP83, another
DAP-component-encoding gene, as a cause of infantile nephronophthisis associated with central nervous system abnormalities in
half of the individuals.Nephronophthisis (MIM 256100) is the most frequent
genetic cause of chronic renal failure in children. It is an
autosomal-recessive chronic tubulointerstitial nephritis
that generally progresses to end-stage renal disease
(ESRD) in childhood. With regards to the age of onset of
ESRD, three clinical presentations have been described:
(1) the infantile form, with ESRD appearing before 5 years,
(2) the juvenile form (mean age of onset 13 years), and (3)
the young adult form. These different forms share histolog-
ical features characterized by the development of massive
interstitial fibrosis with abnormal thickness of the tubular
basement membranes and at the later stage formation of
cysts mainly distributed at the cortico-medullary junction.
Infantile nephronophthisis is generally characterized by
hyperechogenic kidneys with variable kidney sizes.1
Some affected individuals with nephronophthisis also
present with extrarenal symptoms: retinitis pigmentosa,
intellectual disability, cerebellar ataxia, bone anomalies,
or liver fibrosis, defining syndromes referred as nephro-
nophthisis-related ciliopathies (NPHP-RCs).2
Ciliopathies are clinically and genetically heterogeneous
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The Ammary and/or motile cilia (primary ciliary dyskinesia [MIM
244400]). Primary cilia, sensory generally nonmotile cilia,
are present on most cells in vertebrates and control key
signaling pathways during development and tissue
homeostasis.2,3 In total, more than 17 genes have been
associated with the NPHP-RCs and causative mutations
in these genes account for approximately 30%–50% of
the NPHP-RC cases.4,5 Almost all these genes encode for
proteins localized to the proximal region of the primary
cilium either at the transition zone (including NPHP1
[MIM 607100], NPHP4 [MIM 6007215], and RPGRIP1L/
NPHP8 [MIM 610937]) or at the inversin compartment
(INVS/NPHP2 [MIM 243305], NPHP3 [MIM 608002],
NEK8/NPHP9 [MIM 609799], and ANKS6/NPHP16 [MIM
615370]) where they are implicated in key cilia-dependent
signaling pathways.2,4 Notably, mutations in INVS/NPHP2,
NPHP3, andNEK8/NPHP9 have been associated with infan-
tile nephronophthisis.6–8 More recently, our group and
others have shown that mutations in genes encoding
intraflagellar transport (IFT)-A as well as in some IFT-B sub-
units and IFTmotors result in isolated nephronophthisis as
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mediates the transport of the ciliary components into the
cilium and along the axoneme.12
Ciliogenesis starts with the docking of the basal body to
the plasma membrane. This process is mediated by struc-
tures present at the mother centriole called distal append-
ages (DAPs). The DAPs are projected radially from the distal
end of themother centriole and dock onto the cytoplasmic
leaflet of the plasma membrane where they form the tran-
sition fibers.13 The transition fibers together with the adja-
cent transition zone are thought to constitute a molecular
filter limiting the exchanges between the ciliary compart-
ment and the cytoplasm.14 The molecular composition
of DAPs was recently characterized and their function in
ciliogenesis has been partially elucidated (see below).15–18
Mutations in genes encoding DAP components have
been associated with NPHP-RC, including CEP164/
NPHP15 (MIM 614848) in Joubert syndrome19 (MIM
613820) and more recently SCLT1 (MIM 611399) in one
individual with a severe ciliopathy phenotype consistent
with orofaciodigital syndrome type IX (MIM 258865).20
In order to identify additional genes mutated in ciliopa-
thies, we performed two independent NGS approaches on
a large cohort of affected individuals. First, we analyzed a
cohort of 200 individuals with NPHP-RCs by applying
exon-enriched NGS targeting up to 1,221 genes associated
with cilia including all known genes associated with cilio-
pathies (‘‘ciliome sequencing’’)9,21,22 and consecutive
barcoded NGS on a SoliD5500 (Life tech) or HiSeq 2500
(Illumina) platform. Written informed consent was
obtained from all individuals enrolled in this study and/
or from parents and approved by the Comite´ de Protection
des Personnes pour la Recherche Biome´dicale Ile de
France II. Compound heterozygous mutations in CEP83
(CCDC41) were identified in three unrelated individuals
with NPHP-RC (Table 1, Figure 1, and Figure S1 available
online). All three affected individuals (NPH2036,
NPH1402, and NPH1412-II1) presented with a severe renal
involvement progressing to ESRD before the age of 5 years.
We subsequently screened 19 unrelated individuals with
early-onset nephronophthisis for CEP83 mutations in the
coding exons by Sanger sequencing. Recessive mutations
were identified in two additional unrelated persons, indi-
viduals NPH982 and NPH1018 (Table 1, Figures 1 and
S1). Segregation of the identified mutations was confirmed
whenever the parental DNA was available (Figure S1).
Notably, individual NPH1412-II1 carried the same muta-
tions as his brother, NPH1412-II2, who presents a similar
phenotype (Table 1 and Figure S1). In parallel, we screened
a worldwide cohort of 1,056 individuals with NPHP-RCs by
exon sequencing of DAP components (CEP89 [CCDC123/
CEP123, MIM 615470], CEP83, SCLT1, and FBF1) by a
high-throughput barcoded NGS technique.23 Written
informed consent was obtained from all individuals
enrolled in this study and approved by the institutional
review boards at the University of Michigan and the
Boston Children’s Hospital. Two homozygous mutations
in CEP83 were identified in two unrelated persons with906 The American Journal of Human Genetics 94, 905–914, June 5, 2early-onset nephronophthisis, individuals F374-21 and
A4037-21 (Table 1, Figures 1 and S1). In these two families,
the 17 genes already known to be associated with NPHP-
RCwere screened in order to exclude another genetic cause
but no explanatory mutations were detected.
In total, we identified ten different biallelic mutations in
CEP83 in eight individuals with isolated (three individuals)
or syndromic (five individuals) nephronophthisis. The
affected individuals reached ESRD at 1 to 4 years of age
(mean age of 3). Severe tubulointerstitial lesions were
present in all individuals (Figure 2). Similar to what we pre-
viously reported for INVS/NPHP2 and NPHP3 mutations,8
two types of nephrohistological alterations were found in
individuals with CEP83mutations: (1) in three individuals
(NPH1412, A4037-21, and NPH982), microcystic tubular
dilatations were prominent and associated with tubular
atrophy and interstitial fibrosis and (2) in two individuals
(NPH2036 and NPH982), atrophic tubules with thickening
of the basement membranes and massive interstitial
fibrosis were observed. Moreover, high blood pressure
was present in two individuals (Table 1) as already
described in the early onset of the kidney disease.8 Four
affected persons (NPH1402, NPH2036, A4037-21,
NPH1018) presented with neurological alterations,
including speech delay, intellectual disability, and/or
hydrocephalus supported by cerebral MRI in combination
with ophthalmologic defects, strabismus and retinal
degeneration, in two individuals (NPH2036 and
NPH1018, respectively). Two individuals presented with
liver alterations, hepatic cytolysis and cholestasis
(NPH2036) and severe portal septal fibrosis with mild
thickening of arterial walls and increase in the number of
the biliary canalicules on liver biopsy (NPH982). Moreover,
individual A4037-21 exhibited a more severe phenotype
with ESRD at 1 year of age, hydrocephalus, intellectual
disability, facial dysmorphism, and heart anomaly compli-
cated by triple X syndrome (47, XXX), which could not
explain this clinical association (Table 1, Figures 1 and S1).
Three affected individuals carried homozygous muta-
tions of CEP83 (RefSeq accession number NM_016122.2):
one missense mutation (c.260T>C [p.Leu87Pro]), one in-
frame deletion (c.2050_2052del [p.Glu684del]), and one
frameshift mutation in the last exon (c.2007del
[p.Glu669Aspfs*14]) leading to a truncated protein
(Table 1, Figures 1 and S1). Four families carried compound
heterozygous mutations of CEP83: one truncating
mutation (c.121C>T [p.Arg41*]; c.241C>T [p.Gln81*];
c.625C>T [p.Arg209*]; c.1530C>A [p.Cys510*]) in trans
with a missense mutation (c.1532G>C [p.Arg511Pro]) or
an in-frame deletion (c.335_352del [p.Pro112_Leu117del];
c.2075_2077del [p.Gln692del]). All the mutated or deleted
amino acids are evolutionarily highly conserved and
amino acid changes are predicted to be damaging
(Figure 1D, Table 1). Almost all individuals carried at least
one missense mutation or an in-frame deletion resulting
in loss of one or a few amino acids, indicating that the
function of the proteinmay be partially preserved (Figure 1,014
Table 1. Genetic and Clinical Characteristics of Individuals with CEP83 Mutations
Individual(s) Ethnic Origin
Parental
Consanguinity
Nucleotide
Alteration(s)a
Deduced
Protein Change
Exon (Zygosity,
Segregation) AA Conservation
PolyPhen2,
Mut.taster
Nephronophthisis
Age of ESRD
Additional Clinical
Features
NPH2036-II1 European
(France)
no c.121C>T p.Arg41* 3 (Het, p) NA NA 3 years mild intellectual
disability, strabismus,
hepatic cytolysis,
cholestasis
c.335_352del p.Pro112_Leu117del 5 (Het, m) NA NA
NPH1402 European
(France)
no c.241C>T p.Gln81* 4 (Het, m) NA NA 4.5 years speech delay,
hydrocephalus
c.2075_2077del p.Gln692del 17 (Het, p) NA NA
F374-21 European no c.260T>C p.Leu87Pro 4 (Hom) D. rerio (except Xenopus) D(0.944), DC(0.99) ND ND
NPH1018 European
(France)
no c.625C>T p.Arg209* 7 (Het) NA NA 4 years intellectual disability,
retinitis
c.1532G>C p.Arg511Pro 13 (Het) G. gallus D(0.915), DC(0.941)
NPH1412-II1, -II2 European
(Poland/
France)
no c.1530C>A p.Cys510* 13 (Het, m) NA NA 3 years high blood pressure
c.1532G>C p.Arg511Pro 13 (Het, p) G. gallus D(0.915), DC(0.941)
NPH982 Turkish yes c.2050_2052del p.Glu684del 17 (Hom) D. reriob NA 3 years high blood pressure,
hepatic fibrosis
A4037-21 Latino no c.2007del p.Glu669Aspfs*14 17 (Hom) NA NA, DC(1.00) 1 year hydrocephalus,
intellectual disability,
dysmorphism, triple X
syndrome (47, XXX),
heart anomaly
Abbreviations are as follows: D, predicted ‘‘Damaging;’’ DC, predicted ‘‘Disease causing;’’ Het, heterozygous; Hom, homozygous; m, maternal; NA, not applicable; ND, no data; NPH, nephronophthisis; p, paternal.
acDNA mutations are numbered according to human cDNA reference sequence NM_016122.2 (CEP83), where þ1 corresponds to the A of ATG start translation codon.
bThis residue (Glu at 684) is conserved down to D. rerio except G. gallus and X. tropicalis, which have Asp instead.
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Figure 1. Identification of Ten Different CEP83 Mutations in Seven Families with NPHP-RC
(A) Exon structure of human CEP83 cDNA (RefSeq NM_016122.2). Positions of start codon (ATG) and of stop codon (TGA) are indicated
in exons 3 and 17, respectively.
(B) Domain structure of the respective protein. CEP83 contains multiple coiled-coil (red) domains.
(C) Ten homozygous or compound-heterozygous CEP83mutations. For the mutations detected, black arrows indicate positions in rela-
tion to exons and protein domains. Except for the c.335_352del mutation, all mutations concern amino acids found in coiled-coil
domains, mostly in the N-terminal and C-terminal parts of the protein. Family numbers are underlined and predicted translational
changes are indicated. Affected individuals had at least one missense mutation and a deletion.
(D) Partial protein alignment of CEP83 shows evolutionary conservation of the amino acids affected by the identified mutations
(p.Leu87Pro, p.Pro112_Leu117del, p.Arg511Pro, p.Glu684del, and p.Gln692del).Table 1). Notably, only the individual A4037-21 carrying a
homozygous frameshift mutation leading to a truncated
protein exhibited a more severe phenotype of multiple
organ involvement (Table 1, Figures 1 and S1).
CEP83 encodes Centrosomal Protein 83 kDa, CEP83, a
701-residue protein predicted to be mainly composed of
coiled-coil domains (Figure 1B, red). Most of the mutations
result in amino acid alteration in coiled-coil domains
except for the p.Pro112_Leu117del variant (Figures 1B
and 1C) and substitutions in highly conserved residues
(Figure 1D). Deletion of a single amino acid (p.Glu684del
and p.Gln692del) or the introduction of a proline residue
(p.Leu87Pro and p.Arg511Pro) are predicted to affect the
organization of coiled-coil domains through the modifica-
tion of canonical repetition of hydrophobic amino acids
along the alpha helix (Figure 1D).
CEP83 has been recently characterized as a key compo-
nent of DAPs16,17 and is required for the recruitment of
the other components, including its partner CEP164/
NPHP15, to themother centriole.16,17 As previously shown
for CEP164,15,24 depletion of CEP83 affects early steps of
ciliogenesis by preventing docking of the mother centriole908 The American Journal of Human Genetics 94, 905–914, June 5, 2to the primary ciliary vesicle (Figure S2).16,17 In retinal
pigment epithelial (RPE1) cells, CEP83 colocalizes with
CEP164 at DAPs16,17 and is also found at the Golgi appa-
ratus.17 We observed a similar distribution in primary
human skin fibroblasts of healthy controls by using a
CEP83 antibody, with a predominant staining of one of
the two centrioles (Figure 3A, insets, arrows). As previously
shown in other cell types,15,19 CEP164 showed a centriolar
ring-shaped distribution (Figure 3B, insets, arrows) and was
also present in the nucleus.
To evaluate the impact of the identified mutations on
the subcellular distribution of CEP83 and their functional
consequences on DAP biogenesis, the localizations of
CEP83 and CEP164 were analyzed in primary skin fibro-
blasts from two affected individuals (NPH1402 and
NPH1412). Notably, both children carried compound
heterozygous CEP83 mutations resulting in truncated
protein (p.Gln81* and p.Cys510*) in association with an
in-frame deletion or a missense (p.Gln692del and
p.Arg511Pro, respectively; Table 1 and Figure 1). Impor-
tantly, the resulting truncated proteins, if expressed,
cannot be detected by the CEP83 antibody used in this014
Figure 2. Sonographic and Histological
Lesions in Individuals with CEP83 Muta-
tions
(A) Renal ultrasound of individual A4037-
21 shows corticomedullary cysts and
increased echogenicity.
(B–E) Renal biopsy findings in individuals
A4037-21 (B), NPH982 (C), NPH1412 (D),
and NPH2036 (E).
(B) Tubular dilatations are associated with
diffuse interstitial fibrosis in individual
A4037-21. Trichrome light green.
(C–E) Numerous glomeruli are preserved
and others show a retracted glomerular
tuft surrounded by a thickened capsular
basement membrane.
(C)Microcystic tubular dilatations are asso-
ciated with foci of tubular atrophy and
intersitial fibrosis in individual NPH982.
(D) In individual NPH1412, most cortical
tubules are dilated and surrounded by
interstitial fibrosis.
(C and D) Silver impregnation.
(E) Diffuse tubular atrophy, massive
interstitial fibrosis, and focal interstitial
infiltration are associated in individual
NPH2036. PAS.study. Accordingly, CEP83 staining at the centrosome
appeared fainter and dispersed around the centrioles in
fibroblasts from affected individuals compared to control
cells, as shown by CEP83 colabeling with centrin or
g-tubulin (Figure 3A, insets, arrows, and data not shown)
and confirmed by quantification analysis (Figure 3A,
graph). Remarkably, localization of CEP164 was severely
altered in mutated cells with an incomplete ring-shaped
centriolar distribution or even a loss of staining at the
centrosome in some cells (Figures 3B, graph, and S3,
arrows). The distribution of other markers, of DAPs
(CEP89)18 or subdistal appendages (ODF2),16,25 did not
appear to be affected by CEP83 variants (Figure S4, arrows).
These results are in agreement with a partial impairment of
DAP assembly in fibroblasts with CEP83 variants, sparing
the overall organization of the mother centriole. This was
further confirmed by high-resolution 3D fluorescence
microscopy (structured illumination microscopy [SIM];
Figure 3C). Indeed, in affected individuals fibroblasts of
the normal CEP164 ring-shaped organization appeared
clearly defective according to this technique (Figure 3C,
green), whereas ODF2 staining did not appear to be per-
turbed, instead presenting the typical ring-shaped organi-
zation (Figure 3C, red). Finally, immunoblotting in cells
from affected individuals confirmed a reduced CEP83 level
(Figure 3D), whereas CEP164 level was unchanged, indi-
cating that CEP83 variations affect recruitment ofThe American Journal of HumaCEP164 at the centrosome without
any change in its total protein level.
We further confirmed the effects of
CEP83 mutations in kidney biopsies.
In control kidneys, CEP83 andCEP164 localized at one of the two centrioles (Figures
S5A and S5B, insets, arrows). In kidney biopsy from indi-
vidual NPH2036, CEP83 staining appeared fainter at the
centrosome (Figure S5C, arrows) and CEP164 was not
even detected in some centrosomes (50.1% of CEP164-
positive centrosomes versus 83.6% for control;
Figure S5D). Altogether, these results on tissues and cells
from affected individuals suggest that both decreased
CEP83 level (truncated variants) and partial impairment
of the variant proteins, induced by the presence of the
missense or in-frame deletions, probably account for its
inability to assemble properly at the mother centriole, as
well as to recruit CEP164 at the distal part of the mother
centriole.
We next investigated the consequences of amino
acid alterations in CEP83 on its targeting to the centro-
some as well as on its interactions with known partners
in vitro. In transiently transfected RPE1 cells, FLAG-
CEP83 wild-type (WT) was diffusely distributed in the
cytoplasm and nucleus and was also present at the
centrosome where it forms a typical ring-shaped structure
(Figures 4A and S6A, insets). Interestingly, endogenous
CEP164 staining at the centrosome was strongly decreased
in cells transfected with FLAG-CEP83 WT compared
to neighboring nontransfected cells (Figures 4A, 4C,
and S6A), indicating that excess of CEP83 resulted in
a dominant-negative effect on DAP biogenesis. Amongn Genetics 94, 905–914, June 5, 2014 909
Figure 3. Individuals Carrying CEP83 Mutations Show Abnormal DAP Organization
Top: Schematic representation of the structural organization of the centrosome where the localization of different markers of centriolar
subdomains (distal [DAPs] and subdistal [SDAPs]) are stressed.
(A–C) Fibroblasts from control or affected individuals (NPH1402 andNPH1412) were processed for immunofluorescence with antibodies
against centrin (A and B, red; mouse monoclonal [Millipore, 04-1624]) to stain centrioles and CEP83 (A, green; rabbit polyclonal [Sigma,
HPA038161]) or CEP164 (B, green; rabbit polyclonal [Sigma, HPA037606]) or with antibodies against ODF2 (C, red; mouse monoclonal
antibody [clone 1A1, Novus Biological]) to stain SDAPs and CEP164 (C, green). Insets on the right show higher magnification of repre-
sentative centrosomes indicated by a white square in the corresponding images. Arrows indicate CEP83 or CEP164 staining. The inten-
sity of CEP83 (A) and CEP164 (B) staining at the centrosome was quantified by ImageJ (normalized arbitrary units, one representative
experiment out of three [***p< 0.0001], were calculated via Dunn’s Multiple Comparison Test after the analysis of variance ANOVA test)
and shows a reduction in intensity of either CEP83 or CEP164 in affected individual cells compared to control.
(C) Samples were imaged with an n-SIMmicroscope (Nikon). Acquisitions were performed in 3D SIMmode, before image reconstruction
with the NIS-Elements software (Nikon) based on Gustafsson et al.29
Scale bars represent 5 mm.
(D) Cell lysates from fibroblasts were collected and protein levels of CEP83, CEP164, and g-tubulin (mouse monoclonal [Sigma, T5326])
were analyzed by immunoblotting with indicated antibodies. CEP83 level is decreased in affected individuals fibroblasts compared to
control and CEP164 level remains the same.the variant forms of CEP83, p.Pro112_Leu117del,
p.Arg511Pro, and p.Leu87Pro showed similar centrosomal
localization and dominant-negative effects on CEP164
localization as WT protein (data not shown). In contrast,
CEP83 p.Gln692del, p.Glu669Aspfs*14, and p.Glu684del910 The American Journal of Human Genetics 94, 905–914, June 5, 2variants accumulated into the nucleus and failed to
localize at the centrosome (Figures 4A, 4B, and S6B).
CEP164 distribution was not perturbed in cells transfected
with these variants compared to neighboring nontrans-
fected cells (Figure 4A, arrows), thereby showing higher014
Figure 4. CEP83 Mutations Affect Centrosomal Localization and Interaction of CEP83 with CEP164
(A) RPE1 cells were transiently transfected (Lipofectamine LTX, Life Technologies) with plasmids encoding for FLAG-tagged wild-type
(WT) or c.2007del (p.Glu669Aspfs*14) or c.2075_2077del (p.Gln692del) CEP83 variants, fixed, and stained for FLAG (green; mouse
monoclonal [Sigma, F3165]) and CEP164 (red). Scale bar represents 5 mm.
(B and C) Levels of CEP164 (C) and FLAG (CEP83, B) staining at the centrosome were quantified with ImageJ. Centriolar CEP164 inten-
sity is decreased in cells transfected with CEP83 WT compared to cells transfected with CEP83 p.Glu669Aspfs*14 and p.Gln692del
variants (arrows).
(D and E) NIH 3T3 cells were transiently cotransfected with plasmids encoding for FLAG-tagged WT and variant forms of CEP83,
Cep164-myc, and IFT20-GFP. Cell lysates were immunoprecipitated with an anti-FLAG antibody (mouse monoclonal, Sigma, M2).
Cell lysates (bottom) and immunoprecipitates (IP, top) were analyzed by immunoblotting with antibodies against myc (CEP164, rabbit
polyclonal [Santa Cruz Biotechnology, C-19]), FLAG (CEP83, rabbit polyclonal [Cell Signaling Technology, #2368]), and GFP (IFT20,
rabbit polyclonal [Life Technologies, A-6455]) as indicated. Note that three C-terminal CEP83 variants affected the interaction with
CEP164 and IFT120, whereas two N-terminal CEP83 variants did not.
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Figure 5. Fibroblasts from Individuals with CEP83 Mutations Show Mild Ciliary Defects
(A) Fibroblasts from control and affected individuals (NPH1402 and NPH14112) were grown on coverslips, serum starved for 48 hr, then
fixed and processed for immunofluorescence with antibodies against acetylated tubulin (AcTub, red) to stain cilia. Insets show higher
magnification of representative cilia. Scale bar represents 5 mm.
(B) The ability of cells to form cilia, cells with a unique rod like AcTub staining, was quantified from images obtained in (A). Graphs show
the mean5 SEM of at least three independent experiments in which at least 100 cells were counted.
(C) The length of cilia was measured (mm) based on AcTub staining and the results for one representative experiment out of three are
shown.
(B and C) *p < 0.01, **p < 0.001, and ***p < 0.0001 were calculated via Dunn’s Multiple Comparison Test after the analysis of variance
ANOVA test. Ciliogenesis is reducted in fibroblasts of affected individuals which present longer cilia.
(D) Sections of kidney biopsies from control, NPH1402, and NPH2036 individuals were stained for CEP83 (green) and AcTub (red).
Nuclei were stained with Hoechst (blue). Higher magnifications of representative tubules regions are shown on the right panels and cilia
are indicated by white arrows. Cilia present in the lumen of tubules are longer in affected individuals biopsies compared to control.CEP164 staining intensity at the centrosome compared
to cells transfected with WT CEP83 (Figures 4A and 4C).
These results indicate that these variants present a
decreased affinity for the mother centriole and as a result
do not show dominant-negative effects on DAP formation.
We next investigated the ability of CEP83 variants to
interact with its binding partners CEP164 and IFT2017 in
NIH 3T3 cells by coimmunoprecipitation. As shown in
Figures 4D and 4E, CEP164-myc and IFT20-GFP were
efficiently coimmunoprecipitated together with FLAG-
CEP83 WT, showing that these three proteins form
complexes. The C-terminal CEP83 variants (p.Arg511Pro,
p.Glu669Aspfs*14, and p.Gln692del) were impaired in
their ability to interact with CEP164, whereas proteins
harboring p.Leu87Pro and p.Pro112_Leu117del were not
(Figure 4D). Similarly, the interaction with IFT20 appeared
to be decreased by C-terminal CEP83 variants although it
was not affected by N-terminal CEP83 variant proteins
(Figure 4E).
In summary, transfection of wild-type CEP83 results in a
dominant-negative effect on the recruitment of endoge-912 The American Journal of Human Genetics 94, 905–914, June 5, 2nous CEP164 onto the centrosome (Figures 4A–4C). It is
likely that high level of exogenous CEP83 might somehow
prevent the coordinated assembly of CEP164/DAPs onto
the mother centriole by a mechanism that remains to be
characterized. This dominant-negative effect is conserved
for all variants that are efficiently recruited to the centro-
some independently of their capacity to interact with
CEP164 or IFT20 (p.Leu87Pro, p.Pro112_Leu117del, and
p.Arg511Pro) (Figures 4D and 4E). In contrast, variants
p.Gln692del, p.Glu669Aspfs*14, and p.Glu684del are
affected for both centrosome localization and interactions
with their partners CEP164 and IFT20, highlighting the
important role of the last coiled-coil domain encoded by
exon 17 of CEP83 (summarized in Table S1).
As mentioned above, DAPs play a crucial role during
ciliogenesis (Figure S2). We confirmed that CEP83 localizes
at the base of both primary and motile cilia in vitro and
in vivo (Figures S7 and S8). This is consistent with the
ciliary dysfunction phenotype observed in affected indi-
viduals, associated primary cilia defects (nephronophthisis
and retinal degeneration), and possibly motile cilia defects014
as suggested by ventricular dilatation and hydrocephalus
observed in some of the affected individuals (A4037-21)
similar to those described for individuals with variations
in SDCCAG8/NPHP10.26 We therefore examined the ability
of fibroblasts from affected individuals (NPH1402 and
NPH1412) to form primary cilia. Upon serum starvation,
ciliogenesis was mildly but statistically significantly
affected in fibroblasts from affected individuals with
the percentage of ciliated cells decreased compared to
control fibroblasts (Figures 5A and 5B). The formed cilia
presented no obvious change in the ciliary composition
because localization of the ciliary components CEP290,
ANKS6, IFT140, or ARL13B were not perturbed (Figure S9
and data not shown). However, cilia present in both
fibroblasts (Figures 5C) of affected individuals were sig-
nificantly longer compared to controls. This phenotype
was also observed in kidney biopsies from affected individ-
uals NPH1402 and NPH2036 (Figure 5D, right panels,
arrows), similar to our observations in other NPHP-RC
proteins.9,27
Together, our results show that fibroblasts and tubular
renal cells from affected individuals exhibit ciliogenesis
defects probably resulting from an altered assembly of
DAPs, which would affect docking of altered mother
centriole to the ciliary primary vesicle (Figure S2). In addi-
tion, defects in IFT20 interaction by most of the variants
probably contribute to ciliary defects because IFT20 was
shown to participate in ciliogenesis through vesicular traf-
ficking from the Golgi apparatus.28
In summary, we have identified mutations in CEP83 as
causing early-onset nephronophthisis and intellectual
disability, adding another component of the DAPs of
centrioles to the list of defective proteins in NPHP-RC.
We therefore propose ‘‘NPHP18’’ as an alias for CEP83.Supplemental Data
Supplemental Data include nine figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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